Abstract:Objective:To analyze the clinical features of type 2 diabetic patients with insulin autoimmune syndrome after treatment with exogenous insulin.Methods:A total of 106 patients with type 2 diabetes diagnosed with exogenous insulin-related insulin autoimmune syndrome (EIAS) were included from September 2017 to March 2019 in the Department of Endocrinology, Zhongshan Hospital, Fudan University. The clinical data, physical examination, and laboratory examination results of patients were collected.Results:Of the 106 patients, 84 (79.24%) used premixed human insulin or premixed insulin analogs, and 18 patients (16.98%) presented recurrent hypoglycemia. The arginine stimulation test showed that the median value of the baseline insulin was 73.40 (23.07-146.75) μU/ml, and the median ratio of 4 minute insulin to 0 minute insulin was 1.27 (1.03-1.85), with the mean of the ratio 1.72±1.47. The ratio of baseline insulin (μU/ml) to C-peptide (ng/ml) was 44.60 (14.92-87.93), with an average of 81.92±130.93. Taking the two-fold upper limit of fasting insulin reference value (49.8 μU/ml) as the cut-off point, the subjects were divided into insulin accumulation group (baseline insulin≥49.8 μU/ml) and insulin non-accumulation group (baseline insulin <49.8 μU/ml). Among the 66 patients in the insulin accumulation group, 14 patients had hypoglycemia (21.21%) and 4 patients in the insulin non-accumulation group presented hypoglycemia (10%). The ratio of 4 minute insulin to baseline insulin, ratio of baseline insulin to C-peptide, blood glucose level standard deviation (SDBG) and maximum blood glucose fluctuation amplitude (LAGE) in the insulin accumulation group were significantly higher than those in the insulin non-accumulation group (all P<0.05). Among 66 patients in the insulin accumulation group, 36 patients changed the type of insulin preparafion (insulin treatment group), 30 patients were changed from insulin to oral hypoglycemic agents (oral medication group). After treatment, both SDBG and LAGE in the two groups were significantly lower than before treatment ( P<0.05). Conclusions:With the aggravation of exogenous insulin accumulation, the fluctuation of blood glucose and the proportion of hypoglycemia were significantly increased. There was a characteristic change in islet function in patients with insulin autoimmune syndrome. After arginine stimulation, there was no significant peak of insulin secretion, showing a " high-level" curve. The baseline insulin/C-peptide ratio was significantly increased. The prognosis of EIAS patients is good after timely diagnosis and adjustment of treatment.

The Influence Research of Inducing Immune Reaction of the Patients with Insulin Resistance to Sicca Syndrome

[Effect of Prescriptions Replenishing Vital Essence, Tonifying Qi and Activating Blood on TNF-alpha, IL-1beta Expressions in Serum and Submaxillary Gland of NOD Mice with Sjogren's Syndrome].

[Effect of Yangyin Yiqi Huoxue Recipe on Immune Balance of Th1/Th2 in Serum and Submaxillary Glands of NOD Mice with Sjogren's Syndrome].

Effect of Chinese Herbal Medicines for Nourishing Yin, Supplementing Qi, and Activating Blood on Reproductive Endocrine Activity and Immune Functions in Patients with Primary Sjogren's Syndrome.

Evaluation of Diagnostic Efficiency of Clinical Indicators in Patients with Primary Sjogren′s Syndrome

Analysis on clinical features of 106 type 2 diabetic patients complicated with insulin autoimmune syndrome

The efficacy and mechanism for action of iguratimod in primary Sjögren’s syndrome patients

The Critical Biomarkers Identification of Insulin Signaling Involved in Initiating cAMP Signaling Mediated Salivary Secretion in Sjogren Syndrome: Transcriptome Sequencing in NOD Mice Model

Expressions of Type I-III Interferons in Sjögren's Syndrome and Non-Sjögren's Dry Eye

Serum immunogiobulin A and its clinical role in primary Sjogren's syndrome

Association of systemic immune-inflammation index with insulin resistance and prediabetes: a cross-sectional study

Effect of insulin resistance on the vascular endothelial function in the patiens with coronary heart disease

Serum Irisin Level and Its Correlation with Insulin Resistance in Patients with Type 2 Diabetes

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications

Identification and Verification of Inflammatory Biomarkers for Primary Sjögren’s Syndrome

Primary Study on System of Interleukin-2 and Interleukin-2 Receptor of Sjogren′s Syndrome

Preliminary Investigation on Diagnostic Value of Polyethylene Glycol Precipitation and Gel Filtration Chromatography in Insulin Autoimmune Syndrome

Clinical study of effectiveness and safety of Iguratimod in treating primary Sj(o)gren's syndrome

Expression of interleukin 27 in the sera of patients with Sj(o)gren's syndrome and its regulation on interleukin 10

The analysis of relevant factors in intensive therapy to ameliorate insulin resistance in newly diagnosed type 2 diabetic patients